New Rules On Medical Marijuana Research
The U.S Drug Enforcement Administration has relaxed its regulations on medical marijuana research. The new regulations allow researches to skip a step in the approval process if they want to modify their studies by obtaining more CBD- or cannabinol – an active chemical in marijuana. This change essentially means less paperwork is needed and the process is sped up to obtain more CBD for research purposes. The Pennsylvania Medical Society believes this change will open many doors for future research opportunities. They would prefer the ability to conduct more research and clinical studies before the state makes any moves to...
Read More
Recent Comments